Literature DB >> 33654130

Altered metabolic and inflammatory transcriptomics after cardiac surgery in neonates with congenital heart disease.

Parag N Jain1, Matthew Robertson2, Javier J Lasa3, Lara Shekerdemian3, Danielle Guffey2, Yuhao Zhang2, Krithika Lingappan3, Paul Checchia3, Cristian Coarfa4.   

Abstract

The study examines the whole blood transcriptome profile before and after cardiopulmonary bypass (CPB) in neonates with hypoplastic left heart syndrome (HLHS), a severe form of congenital heart disease, that can develop low cardiac output syndrome (LCOS). Whole blood mRNA transcriptome profiles of 13 neonates with HLHS before and after their first palliative surgery were analyzed to determine differentially expressed genes and pathways. The median age and weight at surgery were 4 days and 3.2 kg, respectively. Of the 13 patients, 8 developed LCOS. There was no significant difference between CPB, aortic cross clamp, deep hypothermic cardiac arrest times between patients that develop LCOS and those that do not. Upon comparing differential gene expression profiles between patients that develop LCOS and those that do not in pre-operative samples, 1 gene was up-regulated and 13 were down regulated. In the post-operative samples, 4 genes were up-regulated, and 4 genes were down regulated when patients that develop LCOS were compared to those that do not. When comparing post-operative samples to pre-operative samples in the patients that do not develop LCOS, 1484 genes were up-regulated, and 1388 genes were down regulated; while patients that developed LCOS had 2423 up-regulated genes, and 2414 down regulated genes for the same pre to post-operative comparison. Pathway analysis revealed differential regulation of inflammatory pathways (IL signaling, PDGF, NOTCH1, NGF, GPCR) and metabolic pathways (heme metabolism, oxidative phosphorylation, protein metabolism including amino acid and derivatives, fatty acid metabolism, TCA cycle and respiratory electron transport chain). By identifying altered transcriptome profiles related to inflammation and metabolism in neonates with HLHS who develop LCOS after CPB, this study opens for exploration novel pathways and potential therapeutic targets to improve outcomes in this high-risk population.

Entities:  

Mesh:

Year:  2021        PMID: 33654130      PMCID: PMC7925649          DOI: 10.1038/s41598-021-83882-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  43 in total

Review 1.  DNA microarrays: implications for cardiovascular medicine.

Authors:  Stuart A Cook; Anthony Rosenzweig
Journal:  Circ Res       Date:  2002-10-04       Impact factor: 17.367

2.  Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting.

Authors:  V Tomic; S Russwurm; E Möller; R A Claus; M Blaess; F Brunkhorst; M Bruegel; K Bode; F Bloos; J Wippermann; T Wahlers; H-P Deigner; J Thiery; K Reinhart; M Bauer
Journal:  Circulation       Date:  2005-11-08       Impact factor: 29.690

Review 3.  Myocardial substrate metabolism in the normal and failing heart.

Authors:  William C Stanley; Fabio A Recchia; Gary D Lopaschuk
Journal:  Physiol Rev       Date:  2005-07       Impact factor: 37.312

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Gene expression profile after cardiopulmonary bypass and cardioplegic arrest.

Authors:  Marc Ruel; Cesario Bianchi; Tanveer A Khan; Shu Xu; John R Liddicoat; Pierre Voisine; Eugenio Araujo; Helen Lyon; Isaac S Kohane; Towia A Libermann; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

6.  Metabolomic and bioinformatic analyses in asphyxiated neonates.

Authors:  Ching Yan Chu; Xin Xiao; Xiao Guang Zhou; Tze Kin Lau; Michael Scott Rogers; Tai Fai Fok; Lap Kay Law; Chi Pui Pang; Chi Chiu Wang
Journal:  Clin Biochem       Date:  2006-02-07       Impact factor: 3.281

7.  Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx.

Authors:  Chloé B Steen; Chih Long Liu; Ash A Alizadeh; Aaron M Newman
Journal:  Methods Mol Biol       Date:  2020

8.  Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.

Authors:  Mark D Reller; Matthew J Strickland; Tiffany Riehle-Colarusso; William T Mahle; Adolfo Correa
Journal:  J Pediatr       Date:  2008-07-26       Impact factor: 4.406

9.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

10.  Differential Expression of Extracellular Matrix and Adhesion Molecules in Fetal-Origin Amniotic Epithelial Cells of Preeclamptic Pregnancy.

Authors:  Myung-Sun Kim; Ji Hea Yu; Min-Young Lee; Ah Leum Kim; Mi Hyun Jo; MinGi Kim; Sung-Rae Cho; Young-Han Kim
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

View more
  2 in total

Review 1.  Accelerated Cardiac Aging in Patients With Congenital Heart Disease.

Authors:  Dominga Iacobazzi; Valeria Vincenza Alvino; Massimo Caputo; Paolo Madeddu
Journal:  Front Cardiovasc Med       Date:  2022-05-26

2.  Analysis of risk factors of low cardiac output syndrome after congenital heart disease operation: what can we do.

Authors:  Bangrong Song; Haiming Dang; Ran Dong
Journal:  J Cardiothorac Surg       Date:  2021-05-17       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.